or Try an Advanced Search...

    Technical Analysis for LADX - Ladrx Corp

    Grade Last Price % Change Price Change
    F 1.6000 7.38% 0.1100
    LADX closed up 7.38 percent on Tuesday, September 19, 2023, on 7 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical LADX trend table...
    Date Alert Name Type % Chg
    Stochastic Buy Signal Bullish 0.00%
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Oversold Stochastic Weakness 0.00%
    MACD Bearish Signal Line Cross Bearish 7.38%
    New 52 Week Closing Low Bearish 7.38%
    180 Bearish Setup Bearish Swing Setup 7.38%
    Older End-of-Day Signals for LADX ...

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    LADX Chart by TradingView
    Basic chart:

    Profile

    LadRx Corporation, a biopharmaceutical company, engages in the discovery and development of therapeutics to treat patients with cancer. The company's advanced drug conjugate, aldoxorubicin that is in late-stage clinical trials is a version of anti-cancer drug doxorubicin. Its pre-clinical therapeutics comprise linker activated drug releases 7, 8, 9, and 10 targeted against cancer The company was formerly known as CytRx Corporation and changed its name to LadRx Corporation in September 2022. LadRx Corporation was incorporated in 1985 and is headquartered in Los Angeles, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Cancer Biopharmaceutical Clinical Medicine Chemotherapy Cancer Treatments Antineoplastic Drugs Aldoxorubicin Cytrx Regulus Therapeutics

    Is LADX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 18 LadRx Announces Reverse Stock Split Effective as of May 17, 2023
    See more LADX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 22.0
    52 Week Low 1.49
    Average Volume 1,479
    200-Day Moving Average 8.7395
    50-Day Moving Average 2.0997
    20-Day Moving Average 1.8735
    10-Day Moving Average 1.7700
    Average True Range 0.1970
    RSI (14) 38.65
    ADX 15.57
    +DI 28.6288
    -DI 42.0301
    Chandelier Exit (Long, 3 ATRs) 1.7490
    Chandelier Exit (Short, 3 ATRs) 2.0810
    Upper Bollinger Bands 2.2369
    Lower Bollinger Band 1.5101
    Percent B (%b) 0.12
    BandWidth 38.7937
    MACD Line -0.2430
    MACD Signal Line -0.2402
    MACD Histogram -0.0028
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.6000
    Resistance 3 (R3) 1.6000 1.6000 1.6000
    Resistance 2 (R2) 1.6000 1.6000 1.6000 1.6000
    Resistance 1 (R1) 1.6000 1.6000 1.6000 1.6000 1.6000
    Pivot Point 1.6000 1.6000 1.6000 1.6000 1.6000
    Support 1 (S1) 1.6000 1.6000 1.6000 1.6000 1.6000
    Support 2 (S2) 1.6000 1.6000 1.6000 1.6000
    Support 3 (S3) 1.6000 1.6000 1.6000
    Support 4 (S4) 1.6000